Ardent Health Partners, LLC (NYSE:ARDT) Receives Average Rating of “Buy” from Analysts

Shares of Ardent Health Partners, LLC (NYSE:ARDTGet Free Report) have received a consensus recommendation of “Buy” from the twelve analysts that are presently covering the company, Marketbeat Ratings reports. Two analysts have rated the stock with a hold recommendation, eight have issued a buy recommendation and two have issued a strong buy recommendation on the company. The average 1-year target price among brokers that have updated their coverage on the stock in the last year is $22.00.

A number of equities research analysts have weighed in on ARDT shares. KeyCorp initiated coverage on Ardent Health Partners in a research note on Friday, October 11th. They set an “overweight” rating and a $24.00 price objective for the company. Royal Bank of Canada reissued an “outperform” rating and set a $23.00 price target on shares of Ardent Health Partners in a research report on Thursday, November 14th. JPMorgan Chase & Co. reiterated a “neutral” rating and set a $20.00 price objective on shares of Ardent Health Partners in a research note on Tuesday, December 17th. Leerink Partners boosted their target price on shares of Ardent Health Partners from $23.00 to $25.00 and gave the stock an “outperform” rating in a research report on Tuesday, November 12th. Finally, Stephens restated an “overweight” rating and issued a $24.00 target price on shares of Ardent Health Partners in a research note on Thursday, September 19th.

View Our Latest Report on Ardent Health Partners

Hedge Funds Weigh In On Ardent Health Partners

Hedge funds and other institutional investors have recently bought and sold shares of the stock. BNP Paribas Financial Markets acquired a new stake in shares of Ardent Health Partners during the 3rd quarter worth approximately $42,000. Financial Management Professionals Inc. bought a new position in Ardent Health Partners during the 3rd quarter worth $50,000. MetLife Investment Management LLC acquired a new stake in Ardent Health Partners in the third quarter worth $135,000. JPMorgan Chase & Co. bought a new stake in Ardent Health Partners in the third quarter valued at $154,000. Finally, Quadrature Capital Ltd bought a new stake in Ardent Health Partners in the third quarter valued at $229,000.

Ardent Health Partners Stock Performance

Shares of Ardent Health Partners stock opened at $13.80 on Thursday. Ardent Health Partners has a 1-year low of $13.69 and a 1-year high of $20.72. The company has a debt-to-equity ratio of 0.78, a current ratio of 1.91 and a quick ratio of 1.78. The firm’s 50-day simple moving average is $16.40.

About Ardent Health Partners

(Get Free Report

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.

Recommended Stories

Analyst Recommendations for Ardent Health Partners (NYSE:ARDT)

Receive News & Ratings for Ardent Health Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ardent Health Partners and related companies with MarketBeat.com's FREE daily email newsletter.